GR1007337B - Αναβραζουσα φαρμακευτικη συνθεση που περιεχει παρακεταμολη και ορφεναδρινη - Google Patents
Αναβραζουσα φαρμακευτικη συνθεση που περιεχει παρακεταμολη και ορφεναδρινηInfo
- Publication number
- GR1007337B GR1007337B GR20100100363A GR20100100363A GR1007337B GR 1007337 B GR1007337 B GR 1007337B GR 20100100363 A GR20100100363 A GR 20100100363A GR 20100100363 A GR20100100363 A GR 20100100363A GR 1007337 B GR1007337 B GR 1007337B
- Authority
- GR
- Greece
- Prior art keywords
- orphenadrine
- pharmaceutical composition
- composition containing
- effervescent
- containing paracetamol
- Prior art date
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 2
- QVYRGXJJSLMXQH-UHFFFAOYSA-N orphenadrine Chemical compound C=1C=CC=C(C)C=1C(OCCN(C)C)C1=CC=CC=C1 QVYRGXJJSLMXQH-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003941 orphenadrine Drugs 0.000 title abstract 2
- 229960005489 paracetamol Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- 230000002917 arthritic effect Effects 0.000 abstract 1
- 239000007938 effervescent tablet Substances 0.000 abstract 1
- 235000010439 isomalt Nutrition 0.000 abstract 1
- 239000000905 isomalt Substances 0.000 abstract 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
Abstract
Μια φαρμακευτική αναβράζουσα σύνθεση για στοματική χορήγηση, με τη μορφή αναβράζοντος δισκίου, που περιέχει σε σταθερό συνδυασμό 450 mg Παρακεταμόλης και 35 mg Κιτρικής Ορφεναδρίνης, κατάλληλη για τη θεραπεία αλγεινών επώδυνων καταστάσεων, που οφείλονται σε αρθρικές ή και μυοσκελετικές διαταραχές. Ιδιαίτερο χαρακτηριστικό της αναβράζουσας σύνθεσης της παρούσας εφεύρεσης είναι ότι περιέχει και τα έκδοχα Γλυκίνη και Isomalt.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20100100363A GR1007337B (el) | 2010-06-24 | 2010-06-24 | Αναβραζουσα φαρμακευτικη συνθεση που περιεχει παρακεταμολη και ορφεναδρινη |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20100100363A GR1007337B (el) | 2010-06-24 | 2010-06-24 | Αναβραζουσα φαρμακευτικη συνθεση που περιεχει παρακεταμολη και ορφεναδρινη |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1007337B true GR1007337B (el) | 2011-07-05 |
Family
ID=44802622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20100100363A GR1007337B (el) | 2010-06-24 | 2010-06-24 | Αναβραζουσα φαρμακευτικη συνθεση που περιεχει παρακεταμολη και ορφεναδρινη |
Country Status (1)
| Country | Link |
|---|---|
| GR (1) | GR1007337B (el) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1010650B (el) * | 2023-01-17 | 2024-03-12 | Ιουλια Κλεωνος Τσετη | Φαρμακευτικη συνθεση παρακεταμολης υπο υδατοδιαλυτη μορφη εντος ερμητικα κλειστου δοχειου για παρασκευη ζεστου ροφηματος |
-
2010
- 2010-06-24 GR GR20100100363A patent/GR1007337B/el active IP Right Grant
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1010650B (el) * | 2023-01-17 | 2024-03-12 | Ιουλια Κλεωνος Τσετη | Φαρμακευτικη συνθεση παρακεταμολης υπο υδατοδιαλυτη μορφη εντος ερμητικα κλειστου δοχειου για παρασκευη ζεστου ροφηματος |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009002196A (es) | Oblea de buprenorfina para terapia de sustitucion de farmacos. | |
| WO2008027350A3 (en) | Acetaminophen pharmaceutical compositions | |
| MX2011013902A (es) | Tratamiento de esclerosis multiple con laquinimod. | |
| MY152279A (en) | Immediate release pharmaceutical compositions comprising oxycodone and naloxone | |
| MY161593A (en) | Oral formulations of cytidine analogs and methods of use thereof | |
| NZ605887A (en) | Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain | |
| IN2012DN06720A (el) | ||
| PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| WO2012007159A3 (en) | Novel gastro-retentive dosage forms | |
| MY173215A (en) | Acetylcysteine compositions and methods of use thereof | |
| EA201590166A1 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| WO2018165404A8 (en) | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol | |
| NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
| IL196425A0 (en) | Pharmaceutical compositions containing ibuprofen and famotidine | |
| MX2015001917A (es) | Composiciones farmaceuticas de memantina. | |
| NZ778223A (en) | Modified release tablet formulations containing phosphodiesterase inhibitors | |
| IN2015DN03921A (el) | ||
| GB2431346C (en) | A combination composition comprising paracetamol and ibuprofen | |
| PE20090625A1 (es) | Composicion farmaceutica que contiene buprenorfina y nalmefeno | |
| MX347237B (es) | Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina. | |
| TNSN08385A1 (en) | Delayed-release glucocorticoid treatment of rheumatoid disease | |
| MX2013003523A (es) | Composicion farmaceutica de dosis baja. | |
| MX2016008027A (es) | Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington. | |
| MX2015010594A (es) | Esteres de testosterona de cadena larga lipobalanceados para suministro oral. | |
| MX2010011193A (es) | Composicion farmaceutica liquida para el tratamiento y prevencion del dolor. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PG | Patent granted |
Effective date: 20110829 |